Moderna is relying on the same patent law provision to fend off an infringement lawsuit that consumer lobbyists recommend the government use to authorize production of generic versions of six brand drugs. Arbutus Biopharma and Genevant Sciences filed a lawsuit ( case no.: 1:22-cv-00252 ) that alleges Moderna used an Arbutus-patented component in Moderna’s coronavirus vaccine without permission. Arbutus developed and patented lipid nanoparticles that Moderna uses to protect and help deliver the messenger RNA in its vaccine, the complaint...